11-55554677-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001920.3(OR4C15):c.209C>T(p.Ala70Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000136 in 1,613,340 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001920.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR4C15 | NM_001001920.3 | c.209C>T | p.Ala70Val | missense_variant | 1/1 | ENST00000642128.1 | NP_001001920.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR4C15 | ENST00000642128.1 | c.209C>T | p.Ala70Val | missense_variant | 1/1 | NM_001001920.3 | ENSP00000493126.1 | |||
OR4C15 | ENST00000314644.2 | c.371C>T | p.Ala124Val | missense_variant | 1/1 | 6 | ENSP00000324958.2 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000140 AC: 35AN: 250678Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135516
GnomAD4 exome AF: 0.000133 AC: 194AN: 1461116Hom.: 0 Cov.: 33 AF XY: 0.000129 AC XY: 94AN XY: 726914
GnomAD4 genome AF: 0.000164 AC: 25AN: 152224Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.371C>T (p.A124V) alteration is located in exon 1 (coding exon 1) of the OR4C15 gene. This alteration results from a C to T substitution at nucleotide position 371, causing the alanine (A) at amino acid position 124 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at